Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Rezolute, Inc. | v465723_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Rezolute, Inc. | v465723_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Rezolute, Inc. | v465723_ex31-1.htm |
| EX-10.1 - EXHIBIT 10.1 - Rezolute, Inc. | v465723_ex10-1.htm |
| 10-Q - FORM 10-Q - Rezolute, Inc. | v465723_10q.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of AntriaBio, Inc. Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Morgan Fields, Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: May 15, 2017
| By: | /s/ Morgan Fields | |
| Morgan Fields | ||
| Principal Accounting Officer |
A signed original of this written statement required by Section 906 has been provided to AntriaBio, Inc. and will be retained by AntriaBio, Inc. Inc. to be furnished to the Securities and Exchange Commission or its staff upon request.